GUIDANCE has been posted by the Therapeutic Goods Administration (TGA) for health professionals involved in providing medicinal cannabis products as an unapproved drug through the Special Access Scheme (SAS) or Authorised Prescriber Scheme.
Visit www.tga.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Nov 16
